News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>CMBI Elevates CHINA LIFE (02628.HK) TP to $20, Expects Steady Uptrend in Full-yr NBV
CMBI has issued a research report elevating its TP for CHINA LIFE (02628.HK)'s H-shares from $15.5 to $20 with an unchanged Buy rating.The broker also lifted its 2024-2026 EPS ...
Reset
Send
The window will close in 5 seconds
<Research>CMBI Elevates CHINA LIFE (02628.HK) TP to $20, Expects Steady Uptrend in Full-yr NBV
Close
Recommend
25
Positive
48
Negative
25
 
SHORT SELL
 
STOCK INFO

CMBI has issued a research report elevating its TP for CHINA LIFE (02628.HK)  +1.420 (+8.659%)    Short selling $587.33M; Ratio 19.463%   's H-shares from $15.5 to $20 with an unchanged Buy rating.

The broker also lifted its 2024-2026 EPS forecasts for the company by 148%/ 38%/ 31% to RMB4.45/ RMB2.58/ RMB2.61 to reflect the company's impressive investment performance and enhanced fundamentals in 3Q and express optimism on its profitability in 4Q.

Related NewsJefferies Downgrades CN Insurers, Prefers PICC GROUP/ PICC P&C
The broker predicted CHINA LIFE's NBV to grow by 17% YoY in 2024.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2024-11-07 16:25.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.